Immunohistochemical localization of EGF, TGF-α, TGF-β, and their receptors in rat corneas during healing of excimer laser ablation

Current Eye Research

Volumn 31, Issue 9, 2006, Pages 709-719

  Tuli, Sonal S ^a   Liu, Ran ^b   Chen, Cui ^b   Blalock, Timothy D ^b   Goldstein, Michael ^a   Schultz, Gregory S ^b,c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c Institute for Wound Research   (United States)

Author keywords

Cornea; EGF; Excimer laser; Growth factors; TGF ; TGF

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR ALPHA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CORNEA EPITHELIUM; EXCIMER LASER; IMMUNOHISTOCHEMISTRY; LASER SURGERY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCAR FORMATION; WOUND HEALING;

ANIMALS; CORNEA; EPIDERMAL GROWTH FACTOR; IMMUNOENZYME TECHNIQUES; KERATOMILEUSIS, LASER IN SITU; MALE; PROTEIN ISOFORMS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, GROWTH FACTOR; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 33748563578     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.1080/02713680600837390     Document Type: Article

References (32)

1. Jester JV, Moller-Pedersen T, Huang J, et al. The cellular basis of corneal transparency: Evidence for 'corneal crystallins.' J Cell Sci. 1999;112(Pt 5):613-622.
2. Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem. 1962;237:1555-1562.
3. Wilson SE, He Y-G, Zieske JD, et al. Effect of epidermal growth factor, hepatocyte growth factor, and keratinocyte growth factor, on proliferation, motility and differentiation of human corneal epithelial cells. Exp Eye Res. 1994;59:665-678.
4. Wilson SE, Liang Q, Kim WJ. Lacrimal gland HGF, KGF, and EGF mRNA levels increase after corneal epithelial wounding. Invest Ophthalmol Vis Sci. 1999;40:2185-2190.
5. van Setten G-B, Tervo T, Viinikka L, et al. Epidermal growth factor in human tear fluid: A minireview. Int. Ophthalmol. 1991;15:359-362.
6. Daniele S, Gilbard JP, Schepens CL. Treatment of persistent epithelial defects in neutrophic keratitis with epidermal growth factor: A preliminary open study. Graefe Arch Clini Exp Ophthalmol. 1992;230:314-317.
7. van Setten GB, Schultz GS. Transforming growth factor alpha is a constant component of human tear fluid. Graefe Arch Clin Exp Opthalmol. 1994;232:523-526.
8. Wilson SE, He YG, Lioyd SA. EGF, EGF receptor, basic FGF, TGF beta-1, and IL-1 alpha mRNA in human corneal epithelial cells and stromal fibroblasts. Invest Optholmol Vis Sci. 1992;33:1756-1765.
9. Khaw PT, Schultz GS, MacKay SL, et al. Detection of transforming growth factor-alpha messenger RNA and protein in human corneal epithelial cells. Invest Ophthalmol Vis Sci. 1992;33:3302-3306.
10. Lim M, Goldstein MH, Tuli S, Schultz GS. Growth factor, cytokine, and protease interactions during corneal wound healing. Ocular Surface. 2003;1(2):53-65.
11. Zieske JD, Takahashi H, Hutcheon AE, Dalbone AC. Activation of epidermal growth factor receptor during corneal epithelial migration. Invest Ophthalmol Vis Sci. 2000;41:1346-1355.
12. Wrana JL, Attisano L, Wieser R, et al. Mechanism of activation of the TGF-beta receptor. Nature. 1994;370:341-347.
13. Chen C, Michelini-Norris B, Stevens S, et al. Measurement of mRNAs for TGFβs and extracellular matrix proteins in corneas of rats after PRK. Invest Ophthalmol Vis Sci. 2000;41:4108-4116.
14. Tarnuzzer RW, Macauley SP, Farmerie WG, et al. Competitive RNA templates for detection and quantitation of growth factors, cytokines, extracellular matrix components and matrix metalloproteinases by RT-PCR. BioTechniques. 1996;20:670-674.
15. Babu JS, Kanangat S, Rouse BT. Limitations and modifications of quantitative polymerase chain reaction. Application to measurement of multiple mRNAs present in small amounts of sample RNA. J Immunol Methods. 1993;165:207-216.
16. Mita T, Yamashita H, Kaji Y, et al. Effect of transforming growth factorβ on corneal epithelial and stromal cell function in a rat wound healing model after excimer laser keratectomy. Graefe Arch Clin Exp Ophthalmol. 1998;236:834-843.
17. van Setten GB, Schultz GS, Macauley S. Growth factors in human tear fluid and in lacrimal glands. Adv Exp Med Biol. 1994;350:315-319.
18. Gupta A, Monroy D, Ji Z, Yoshino K, et al. Transforming growth factor beta-1 and beta-2 in human tear fluid. Curr Eye Res. 1996;15:605-614.
19. Kokawa N, Sotozono C, Nishida K, Kinoshita S. High total TGF-beta 2 levels in normal human tears. Curr Eye Res. 1996;15:341-343.
20. Vesaluoma M, Teppo AM, Gronhagen-Riska C, Tervo T. Release of TGF-beta 1 and VEGF in tears following photorefractive keratectomy. Curr Eye Res. 1997;16:19-25.
21. Tuominen IS, Tervo TM, Teppo AM, et al. Human tear fluid PDGF-BB, TNF-alpha and TGF-beta1 vs corneal haze and regeneration of corneal epithelium and subbasal nerve plexus after PRK. Exp Eye Res. 2001;72:631-641.
22. van Setten GB, Blalock TD, Grotendorst G, Schultz GS. Detection of connective tissue growth factor (CTGF) in human tear fluid: Preliminary results. Acta Ophthalmol Scand. 2003;81:51-53.
23. Uhl M, Aulwurm S, Wischhusen J, et al. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo. Cancer Res. 2004;64:7954-7961.
24. Blalock TD, Yuan R, Lewin AS, Schultz GS. Hammerhead ribozyme targeting connective tissue growth factor mRNA blocks transforming growth factor-beta mediated cell proliferation. Exp Eye Res. 2004;78:1127-1136.
25. Blalock TD, Duncan MR, Varela JC, et al. Connective tissue growth factor expression and action in human corneal fibroblast cultures and rat corneas after photorefractive keratectomy. Invest Ophthalmol Vis Sci. 2003;44:1879-1887.
26. Barone EJ, Yager DR, Pozez AL, et al. Interleukin-1alpha and collagenase activity are elevated in chronic wounds. Plast Reconstr Surg. 1998;102:1023-1027.
27. Pasquale LR, Dorman-Pease ME, Lutty GA, et al. Immunolocalization of TGF-beta 1, TGF-beta 2, and TGF-beta 3 in the anterior segment of the human eye. Invest Ophthalmol Vis Sci. 1993;34:23-30.
28. Nishida K, Kinoshita S, Yokoi N, et al. Immunohistochemical localization of transforming growth factor-β1, -β2, and -β3 latency-assiciated peptide in human cornea. Invest Opthalmol Vis Sci. 1994;35:3289-3294.
29. Assoian RK, Fleurdelys BE, Stevenson HC, et al. Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc Natl Acad Sci U S A. 1987;84:6020-6024.
30. Gartry DS, Muir MG, Lohmann CP, Marshall J. The effect of topical corticosteroids on refractive outcome and corneal haze after photorefractive keratectomy. A prospective, randomized, double-blind trial. Arch Ophthalmol. 1992;110:944-952.
31. Gambato C, Ghirlando A, Moretto E, et al. Mitomycin C modulation of corneal wound healing after photorefractive keratectomy in highly myopic eyes. Ophthalmology. 2005;112:208-218.
32. Cordeiro MF, Mead A, Ali RR, et al. Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcome. Gene Ther. 2003;10:59-71.